arrow
A

A. Matin

Stanford University
H指数:37
被引数:5,815
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extracellular Vesicle-Mediated In Vitro Transcribed mRNA Delivery for Treatment of HER2+ Breast Cancer Xenografts in Mice by Prodrug CB1954 without General Toxicity
2020-03-0246
OAAI
Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation
2018-04-30143
OAAI
Differential fates of biomolecules delivered to target cells via extracellular vesicles
2015-02-23410
OAAI
Sigma S-Dependent Antioxidant Defense Protects Stationary-Phase Escherichia coli against the Bactericidal Antibiotic Gentamicin
2014-10-0131
OAAI
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition
2014-04-0777
OAAI
New Device for High-Throughput Viability Screening of Flow Biofilms
2010-07-01155
OAAI
Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing
2010-04-1730
OAAI
CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy
2009-02-1144
OAAI
Escherichia coli Biofilms Formed under Low-Shear Modeled Microgravity in a Ground-Based System (vol 72, pg 7701, 2006)
2009-02-012
OAAI
Enzyme improvement in the absence of structural knowledge: a novel statistical approach
2007-11-2236
OAAI
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms
2007-10-0185
OAAI
Escherichia coli biofilms formed under low-shear modeled microgravity in a ground-based system
2006-12-01125
OAAI
Analysis of novel soluble chromate and uranyl reductases and generation of an improved enzyme by directed evolution
2006-11-0158
OAAI
New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution
2006-01-2341
OAAI
ChrR, a soluble quinone reductase of Pseudomonas putida that defends against H2O2
2005-06-01124
OAAI
Chromate-reducing properties of soluble Flavoproteins from Pseudomonas putida and Escherichia coli
2004-02-01267
OAAI